Bjerner J, Bratt O, Aas K, Albertsen PC, Fosså SD, Kvåle R, Lilja H, Müller C, Müller S, Stensvold A, Thomas O, Røe OD, Vickers A, Walz J, Carlsson SV, Oldenburg J (2023)
Baseline Serum Prostate-specific Antigen Value Predicts the Risk of Subsequent Prostate Cancer Death-Results from the Norwegian Prostate Cancer Consortium
Eur Urol (in press)
DOI 10.1016/j.eururo.2023.04.028, PubMed 37169639

Gerdtsson A, Torisson G, Thor A, Grenabo Bergdahl A, Almås B, Håkansson U, Törnblom M, Negaard HFS, Glimelius I, Halvorsen D, Karlsdóttir Á, Haugnes HS, Larsen SM, Holmberg G, Wahlqvist R, Tandstad T, Cohn-Cedermark G, Ståhl O, Kjellman A (2023)
Validation of a prediction model for post-chemotherapy fibrosis in nonseminoma patients
BJU Int (in press)
DOI 10.1111/bju.16040, PubMed 37129962

Haug ES, Myklebust TÅ, Juliebø-Jones P, Reisæter LAR, Aas K, Berg AS, Müller C, Hofmann B, Størkersen Ø, Nilsen KL, Johannesen TB, Beisland C (2023)
Impact of prebiopsy MRI on prostate cancer staging: Results from the Norwegian Prostate Cancer Registry
BJUI Compass, 4 (3), 331-338
DOI 10.1002/bco2.214, PubMed 37025477